会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明公开
    • Means and methods for universal calibration of anti-Factor Xa tests
    • Mittel und Verfahren zur universellen Kalibrierung von anti-Faktor-Xa-Tests
    • EP2818871A1
    • 2014-12-31
    • EP13174242.1
    • 2013-06-28
    • Roche Diagnostics GmbHF. Hoffmann-La Roche AG
    • The designation of the inventor has not yet been filed
    • G01N33/86A61K38/48
    • C12Q1/56C12Y304/21006G01N33/86G01N2333/96444G01N2496/00G01N2500/20
    • The present invention concerns diagnostic means and methods in the field of coagulation testing. In particular, it relates to a method for determining an anticoagulant activity elicited by a first anticoagulant in a sample of a subject comprising measuring a first Factor Xa activity in a body fluid test sample of said subject, measuring a second Factor Xa activity in at least one calibrator sample comprising a predefined anticoagulation activity for a second anticoagulant, calculating an universal parameter for the anticoagulation activity comprised in the test sample based on the first and the second measured Factor Xa activities and comparing the said parameter for the anticoagulation activity with predefined ranges of expected anticoagulation activity for at least three anticoagulants. Further provided is a computer program code assisting the method as well as a system for carrying out the said method as well as a kit.
    • 本发明涉及凝血试验领域的诊断手段和方法。 具体地,本发明涉及一种用于测定受试者样品中由第一抗凝血剂引起的抗凝血活性的方法,包括测量所述受试者的体液测试样品中的第一因子Xa活性,至少测量第二因子Xa活性 一个校准品样品包含针对第二抗凝血剂的预定抗凝活性,基于第一和第二测量的因子Xa活动计算包含在测试样品中的抗凝活性的通用参数,并将抗凝活性的所述参数与预定义的范围 预期至少有三种抗凝剂的抗凝活性。 还提供了一种辅助该方法的计算机程序代码以及用于执行所述方法的系统以及套件。